Peptide Biomarkers in Clinical Diagnostics - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Peptide Biomarkers in Clinical Diagnostics

Peptides offer a rich view of disease biology that is unlocked by modern mass spectrometry, but how can we take them from discovery to clinical utility?

  • By

  • Compound Vitality Research Team

  • October 20, 2026

  • 6 min

Share

Original Source(s)

Peptide Biomarkers in Clinical Diagnostics

  • by Compound Vitality Research Team

  • October 20, 2026

Related Content

Aptamer Tests Face the Validation Challenge

Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility

  • October 6, 2026

  • 3 min
FDA approves dostarlimab for advanced rectal cancer

The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.

Anticoagulant recalled over life-threatening risk

Contamination in 22 lots of the injection may cause pulmonary embolism or vascular occlusion; no related adverse events reported.